Clinical Trial

Study of the SCD411 Prefilled Syringe for Treating Adults With Wet Age-Related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema, or Diabetic Retinopathy

Completed Phase 2
View on ClinicalTrials.gov →
Summary
This is a single-arm, multicenter study to evaluate clinical usability of a pre-filled syringe containing SCD411 in adult patients with neovascular Wet Age-Related Macular Degeneration (AMD), Retinal Vein Occlusion (RVO), Diabetic Macular Edema (DME), or Diabetic Retinopathy (DR)
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Completed 2026-06-09
Trial Details
NCT Number NCT07501052
Lead Sponsor Sam Chun Dang Pharm. Co. Ltd.
Conditions Neovascular (Wet) Age-Related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema, Diabetic Retinopathy
Enrollment 33 participants
Start Date 2026-05-13
Primary Completion 2026-05-27 (estimated)
Study Completion 2026-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-08